SAGE Therapeutics Inc and Biogen Inc to Discuss Potential Commercialization Plans for Zuranolone Transcript - Thomson StreetEvents

SAGE Therapeutics Inc and Biogen Inc to Discuss Potential Commercialization Plans for Zuranolone Transcript

SAGE Therapeutics Inc and Biogen Inc to Discuss Potential Commercialization Plans for Zuranolone Transcript - Thomson StreetEvents
SAGE Therapeutics Inc and Biogen Inc to Discuss Potential Commercialization Plans for Zuranolone Transcript
Published Dec 06, 2022
Published Dec 06, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of SAGE.OQ corporate analyst meeting

  
Report Type:

Transcript

Source:
Company:
SAGE Therapeutics Inc
Ticker
SAGE.OQ
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

SAGE Therapeutics Inc Q1 2023 Earnings Call Transcript – 2023-05-02 – US$ 54.00 – Edited Transcript of SAGE.OQ earnings conference call or presentation 2-May-23 12:00pm GMT

SAGE Therapeutics Inc at Stifel CNS Days (Virtual) Transcript – 2023-03-29 – US$ 54.00 – Edited Transcript of SAGE.OQ presentation 29-Mar-23 3:00pm GMT

SAGE Therapeutics Inc at Cowen Health Care Conference Transcript – 2023-03-06 – US$ 54.00 – Edited Transcript of SAGE.OQ presentation 6-Mar-23 3:30pm GMT

SAGE Therapeutics Inc Q4 2022 Earnings Call Transcript – 2023-02-16 – US$ 54.00 – Edited Transcript of SAGE.OQ earnings conference call or presentation 16-Feb-23 1:00pm GMT

SAGE Therapeutics Inc at JPMorgan Healthcare Conference Transcript – 2023-01-10 – US$ 54.00 – Edited Transcript of SAGE.OQ presentation 10-Jan-23 6:30pm GMT

SAGE Therapeutics Inc at Piper Sandler Healthcare Conference Transcript – 2022-12-01 – US$ 54.00 – Edited Transcript of SAGE.OQ presentation 1-Dec-22 1:00pm GMT

SAGE Therapeutics Inc Q3 2022 Earnings Call Transcript – 2022-11-08 – US$ 54.00 – Edited Transcript of SAGE.OQ earnings conference call or presentation 8-Nov-22 1:00pm GMT

SAGE Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2022-09-12 – US$ 54.00 – Edited Transcript of SAGE.OQ presentation 12-Sep-22 7:40pm GMT

SAGE Therapeutics Inc Q2 2022 Earnings Call Transcript – 2022-08-02 – US$ 54.00 – Edited Transcript of SAGE.OQ earnings conference call or presentation 2-Aug-22 12:00pm GMT

SAGE Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript – 2022-06-13 – US$ 54.00 – Edited Transcript of SAGE.OQ presentation 13-Jun-22 10:20pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "SAGE Therapeutics Inc and Biogen Inc to Discuss Potential Commercialization Plans for Zuranolone Transcript" Dec 06, 2022. Alacra Store. May 02, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/SAGE-Therapeutics-Inc-and-Biogen-Inc-to-Discuss-Potential-Commercialization-Plans-for-Zuranolone-T15407815>
  
APA:
Thomson StreetEvents. (2022). SAGE Therapeutics Inc and Biogen Inc to Discuss Potential Commercialization Plans for Zuranolone Transcript Dec 06, 2022. New York, NY: Alacra Store. Retrieved May 02, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/SAGE-Therapeutics-Inc-and-Biogen-Inc-to-Discuss-Potential-Commercialization-Plans-for-Zuranolone-T15407815>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.